As per DelveInsight analysis of the stereotactic surgery devices market, the demand for stereotactic surgery devices is primarily witnessing an increase due to the rising incidence of various cancers such as brain cancers, and the increasing prevalence of movement disorders such as Parkinson’s disease. Additionally, the growing popularity of minimally invasive stereotactic radiosurgery and radiotherapy, and innovation in product development also play a key role in establishing a positive growth trend in the stereotactic surgery devices market during the forecast period from 2022 to 2027.
DelveInsight’s Stereotactic Surgery Devices Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies market shares, challenges, stereotactic surgery devices market drivers, barriers, and trends, and key stereotactic surgery devices companies in the market.
Stereotactic Surgery Devices
Stereotactic surgery is a technique used to execute procedures such as ablation, biopsy, lesion, injection, stimulation, implantation, and radiosurgery. It is a minimally invasive approach that uses a coordinate system to locate small targets inside the body. Stereotactic surgery is also known as surgical navigation. Stereotactic surgery devices are specific devices that are used in the performance of stereotactic radiosurgery and radiotherapy. Doctors can use stereotactic surgery devices to pinpoint the exact target site.
Stereotactic Surgery Devices Market Insights
Geographically, the global stereotactic surgery devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of the largest market share, North America is expected to amass a significant revenue share in the global stereotactic surgery devices market during the forecast period. This domination is attributed to the factors such rising prevalence of cancers such as lung cancer, the increasing number of cases associated with trigeminal neuralgia, and rising government initiatives regarding disease treatment awareness. Moreover, sophisticated healthcare infrastructure, high disposable income, new product approvals, and increased awareness have also been influential factors in the market growth in this region. However, the superiority of North America will be majorly challenged by the European stereotactic surgery devices market.
Further, the Asia Pacific region has the future potential for growth of the stereotactic surgery devices market. This can be attributed to increasing cancer incidence in the APAC region.
To know more about why North America is leading the market growth in the stereotactic surgery devices market, get a snapshot of the report Stereotactic Surgery Devices Market Trends
Recent Developments in the Stereotactic Surgery Devices Market Report
- In May 2022, Elekta AB launched a new radiosurgery system- Elekta Spirit which is a Next-generation Gamma Knife that will enable more personalized radiosurgery with sub-millimeter accuracy and treatment planning in less than 60 seconds.
- In October 2021, Ion Beam Applications SA announced the launch of the world’s first online platform dedicated to proton therapy.
- In June 2021, NaviNetics Inc. received the premarket product approval from the FDA for their NaviNeticsD1 Stereotactic System.
- In June 2021, Elekta AB received product approval from the US FDA for their linear accelerator-based Elekta harmony radiation therapy system.
- Thus, owing to such developments in the market, there will be rapid growth observed in the stereotactic surgery devices demand during the forecast period.
To read more about the latest highlights related to stereotactic surgery devices, get a snapshot of the key highlights entailed in the Stereotactic Surgery Devices Market Landscape
Key Players in the Stereotactic Surgery Devices Market
The leading stereotactic surgery devices companies such as Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Mevion Medical Systems, Varian Medical Systems, Inc (Siemens Healthineers), inomed Medizintechnik GmbH, adeor medical AG, Bramsys Indústria e Comércio Ltda., Micromar Ind. E Com. LTDA, Mizuho Medical Co. Ltd., Shinva Medical Instrument co.,ltd, Panacea Medical Technologies Pvt. Ltd., Sumitomo Heavy Industries, Ltd, Hitachi Co. Ltd, and others are currently dominating the stereotactic surgery devices market.
COVID-19 Impact Analysis on the Stereotactic Surgery Devices Market
The global stereotactic surgery devices market is expected to witness appreciable growth owing to the increasing incidence of cancers such as brain and spinal cord cancers, among others. The rising prevalence of neurological disorders such as Parkinson’s disease and trigeminal neuralgia can be considered as another factor driving the demand for stereotactic surgery devices, as stereotactic procedures are employed in treating these indications. Additionally, the growth in the geriatric population across the globe further acts as a prominent factor in the growth of stereotactic surgery devices as aging increases the chances of developing certain medical conditions. Moreover, the technological advancements have resulted in an increased interest in developing devices equipped with better features and technologies, such as the Elekta Espirit, which is the latest and most advanced system can be another aspect resulting in the growth of the stereotactic surgery devices market.
However, the stereotactic surgery devices market witnessed a temporary setback due to the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the significant steps during this was the categorization of medical procedures based on urgency and the suspension of numerous elective procedures and outpatient consultations, which reduced the demand for stereotactic surgery devices in the market as the healthcare system guidelines across the globe temporarily focused on all their efforts on the management of COVID-19 patient load during the initial lockdown period, thereby limiting the stereotactic surgery devices market growth for a short time.
Nevertheless, the stereotactic surgery devices market is in the recovery phase with the resumption of activities across various arenas, including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the stereotactic surgery devices market during the forecast period.
Scope of the Stereotactic Surgery Devices Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Product Type: Gamma Knife, Linear Particle Accelerators, Proton Therapy Systems, and Stereotactic Systems
- Market Segmentation By End User: Hospitals, Ambulatory Surgical Centers, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Key Stereotactic Surgery Devices Companies: Elekta AB (OTCMKTS: EKTAY), Accuray Incorporated (NASDAQ: ARAY), Ion Beam Applications S.A. (OTCMKTS: IOBCF), Mevion Medical Systems, Varian Medical Systems, Inc (Siemens Healthineers), inomed Medizintechnik GmbH, adeor medical AG, Bramsys Indústria e Comércio Ltda., Micromar Ind. E Com. LTDA, Mizuho Medical Co. Ltd., Shinva Medical Instrument co.,ltd, Panacea Medical Technologies Pvt. Ltd., Sumitomo Heavy Industries, Ltd (OTCMKTS: SOHVF), Hitachi Co. Ltd (OTCMKTS: HTHIY), among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The stereotactic surgery devices market size is expected to grow at a CAGR of 5.37% during the forecast period 2022–2027.
Which MedTech key players in the stereotactic surgery devices market are set to emerge as the trendsetter explore @ Stereotactic Surgery Devices Companies
Table of Contents
| 1 | Stereotactic Surgery Devices Market Report Introduction |
| 2 | Stereotactic Surgery Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Stereotactic Surgery Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Stereotactic Surgery Devices Market |
| 7 | Stereotactic Surgery Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the stereotactic surgery devices market will be growing by 2027? Click to get a snapshot of the Stereotactic Surgery Devices Market Analysis
Related Reports
Brain Cancer Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain cancer companies including Merck, Genentech, Bayer, among others.
Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord injury companies, including AbbVie, GNT Pharma, Healios, among others.
Surgery and Radiation Therapy in Brain Cancer Market
Surgery and Radiation Therapy in Brain Cancer Market Insights, Competitive Landscape and Market Forecast – 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key surgery and radiation therapy in brain cancer companies including Mevion, Medtronic, Elekta AB, among others.
Spinal Cord Stimulators Market
Spinal Cord Stimulators Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key spinal cord stimulators companies including Boston, Scientific and corporation, Medtronic plc, Nevro corp., among others.
Brain/Cranial Implants Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain/cranial implants companies, including Stryker, Zimmer Biomet, DePuy Synthes, among others.
Brain Aneurysm Stents Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain aneurysm stents companies, including Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, among others.
Other Trending Reports
Frontotemporal Dementia Market | Follicular Lymphoma Market | Diabetes Market | Blastic Plasmacytoid Dendritic Cell Neoplasm Market | Bevacizumab Biosimilars Insight | Bacterial Conjunctivitis Market | FENEBRUTINIB Market | Peripherally Inserted Central Catheter Devices Market | Cardiac Biomarkers Testing Devices Market | Epstein Barr virus Market | Hay Fever Conjunctivitis Market | Advanced Wound Care Market | Adeno-Associated Virus Vectors in Gene Therapy Market | Acute Respiratory Distress Syndrome Market | Primary Immune Deficiency Market
Latest Healthcare Blogs
- Portfolio Management in Healthcare
- Obesity Treatment Landscape
- Digital Therapeutics in Mental Health
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187